AHSC seminar: new tests and treatments for prostate cancer
At the next AHSC seminar, an expert from the Trust will pair up with an academic from the College to talk about their latest work to detect and treat prostate cancer.
Dr Sylvain Ladame, from Imperial College’s department of bioengineering, will talk about his work to develop new screening tests for early diagnosis of prostate cancer.
Dr Ladame and his team are developing a low-cost test to detect early-stage prostate cancer at the point of care. The test works by detecting biomarkers in blood to help diagnose prostate cancer with higher specificity than tests that are currently offered, and can provide results in a few hours.
The researchers hope the test, which will use a small sample of blood, could eventually be available in GP surgeries.
Professor Hashim Ahmed, consultant urological surgeon at the Trust, will outline his work on developing pioneering new treatment which could improve the lives of thousands of men with an enlarged prostate.
The new procedure, which is called Rezum Water Vapour, injects small amounts of steam into the prostate. The steaming process permeates throughout the tissue which then allows the gland to shrink as it repairs itself, relieving the symptoms.
The new technique aims to replace a procedure which takes over an hour and includes 2–3 days of hospital stay with a 10–15 minute procedure under sedation/local anaesthetic with patients able to go home that same day.
Professor Ahmed was the first to perform the procedure in London at Charing Cross Hospital.
Lunch will be served after the presentations.